DalsnaFinance › IPOs › Prelude Therapeutics › IPO
Prelude Therapeutics Inc completed its initial public offering on NASDAQ on September 25, 2020, pricing at $19.00 a share.
| Ticker | PRLD |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | September 25, 2020 |
| Offering price | $19.00 |
| Shares offered | 8,325,000 |
| Total raised | $158M |
Prelude Therapeutics Inc sold 8,325,000 shares at $19.00 each on NASDAQ. Multiplied out, that is $158.2 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $158 million total recorded for the deal.
Prelude Therapeutics Inc — quote, profile and latest news →
Source: SEC EDGAR filings for Prelude Therapeutics Inc. This page is general information, not investment advice.